title: PET/CT in gynecologic malignancies.
abstract: Ovarian cancer and malignancies of the uterine cervix and corpus are the most commonly encountered gynecologic neoplasms in clinical practice. Although of little value in both diagnosis and early-stage gynecologic malignancy, fluorodeoxyglucose-PET and PET/computed tomography provide accurate detection of metastatic disease in advanced malignancy and better delineation of recurrent disease compared with conventional imaging.
authors.affiliation: Department of Radiology, Holy Name Medical Center, 718 Teaneck Road, Teaneck, NJ 07666, USA; NewYork-Presbyterian Hospital/Columbia University Medical Center, 177 Fort Washington Avenue, New York, NY 10032, USA. Electronic address: brunetti@mail.holyname.org.
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Brunetti
mesh_terms: D003287:Contrast Media; D005260:Female; D019788:Fluorodeoxyglucose F18; D005833:Genital Neoplasms, Female / Q000000981:diagnostic imaging* / Q000473:pathology; D006801:Humans; D064847:Multimodal Imaging; D009362:Neoplasm Metastasis / Q000000981:diagnostic imaging / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging / Q000473:pathology; D009367:Neoplasm Staging; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals
chemical_list: D003287:Contrast Media; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
keywords: Cervical cancer; Endometrial cancer; FDG-PET; Ovarian cancer; PET/CT